Pharmacytimes: Resources: Hepatitis http://www.pharmacytimes.com/condition-resources/hepatitis/condition-rss Hepatitis en-us Sat, 23 Feb 2019 03:33:36 UTC Sat, 23 Feb 2019 03:33:36 UTC Trending News Today: Supreme Court Rejects Case on Drug Price Gouging Law http://www.pharmacytimes.com/news/ Top news of the day from across the health care landscape. Hepatitis C Antivirals Reduce All-Cause Mortality, Liver Cancer http://www.pharmacytimes.com/news/ Longitudinal study of direct-acting antivirals for hepatitis C virus infection finds that treatment provides clinical benefit beyond virologic response, reducing risk for both all-cause mortality and for liver cancer. Trending News Today: Keytruda Fails to Slow Disease, Extend Survival in Liver Cancer Trial http://www.pharmacytimes.com/news/ Top news of the day across the health care landscape. Trending News Today: Liver Fibrosis Treatment Achieves Main Goal of Late-Stage Study http://www.pharmacytimes.com/news/ Top news of the day across the health care landscape. New Therapy Able to Clear Hepatitis C From Donor Lungs Prior to Transplantation http://www.pharmacytimes.com/news/ A novel method of inactivating hepatitis C virus in donor lungs could increase transplantations for patients with end stage lung disease. Sofosbuvir-Based Regimens Well Tolerated in Asian American Patients with HCV http://www.pharmacytimes.com/news/ Sofosbuvir-based regimens for the treatment of hepatitis C were well tolerated in Asian American communities, according to a new study. Study: Hepatitis B Virus Increases Risk of Age-Related Macular Degeneration http://www.pharmacytimes.com/news/ Those with hepatitis B virus have a significantly elevated risk for developing any type of age-related macular degeneration, according to a new report Universal Hepatitis C Screening Shows Benefits Over Current Guidelines http://www.pharmacytimes.com/news/ Analysis finds universal screening for hepatitis C virus infection would be cost effective and provide greater benefit than the currently recommended birth cohort screening. Abuse-Deterrent Formulation of OxyContin Linked to Surge in Hepatitis C Infection http://www.pharmacytimes.com/news/ Injection drug use has been identified as a predominant risk factor for hepatitis C infection and the opioid epidemic has been suggested as a driver of a recent rise in infections. HIV Increases Mortality Risk in Patients With Hepatocellular Carcinoma http://www.pharmacytimes.com/news/ HIV-positive patients with hepatocellular carcinoma had an adjusted 24% increased hazard of death compared to their HIV-negative peers. Analysis Estimates Impact of Interventions on Global HCV Epidemic http://www.pharmacytimes.com/news/ Scaling up prevention, treatment, and screening interventions can make substantial strides toward global hepatitis C elimination. The Importance of Hepatitis C Care After a Cure http://www.pharmacytimes.com/news/ Post-cure care for hepatitis C can reduce the risk of liver disease progression in those with advanced fibrosis and ongoing risk factors for liver injury. Study: Many Cancer Patients Unaware of Hepatitis Infections http://www.pharmacytimes.com/news/ Universal hepatitis screening may be warranted to identify patients with cancer who have undiagnosed viral infections. Trending News Today: Alcohol-Related Disease Beats Hepatitis C as Leading Cause for Liver Transplant http://www.pharmacytimes.com/news/ Top news of the day across the health care landscape Three New Strains of Hepatitis C Virus Create Greater Challenges http://www.pharmacytimes.com/news/ Clear differences in hepatitis C virus worldwide indicate the need to increase global understanding of the virus. New Treatment Option for Advanced Liver Cancer Tops SPT Week in Review http://www.pharmacytimes.com/news/ Top news of the week from Specialty Pharmacy Times. Fewer Than 1% of US Population Currently Infected With Hepatitis C http://www.pharmacytimes.com/news/ Understanding the rate of hepatitis C infection is critical for making strategies to reduce the disease burden among specific populations. Mapping Transmission Core Areas Boosts Targeted Hepatitis C Therapy http://www.pharmacytimes.com/news/ Application of core area methodology can help identify new hepatitis C cases and outbreaks and improve testing and treatment. FDA OKs Cabozantinib for Previously-Treated Hepatocellular Carcinoma http://www.pharmacytimes.com/news/ Cabozantinib’s new indication provides an additional therapeutic option for patients with advanced liver cancer who have been previously treated with sorafenib. Injection Drug Users Not Accurately Reporting HIV Status http://www.pharmacytimes.com/news/ People who inject drugs may not accurately self-report HIV and antiretroviral drug status when entering an HIV prevention study. VSEO N/A